No Image Available

TOCILIZUMAB

Form: Injection

Strength: 162 mg

Reference Brands:

Category: Osteoporosis

PJIA and SJIA are inflammatory diseases that causes pain and swelling in one or more joints in children aged 2 years and above. Actemra 162mg Injection reduces the symptoms like pain and swelling of the joints and also improves your performance in daily activities. It slows down the damage to the cartilage and bone of the joints that occurs due to arthritis.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Denosumab

Strength: 60 mg/mL, 120 mg/1.7 mL

Form: Injection

Reference Brands: Prolia, Xgeva

View Details Get Enquiry
Secukinumab

Strength: 150 mg/mL

Form: Injection

Reference Brands: Cosentyx

View Details Get Enquiry
Zoledronic Acid

Strength: 5 mg/100 mL, 4 mg/5 mL (reconstituted)

Form: Injection

Reference Brands: Reclast, Zometa,Aclasta,

View Details Get Enquiry
Calcium citrate + Alfacalcidol + Zinc Sulphate Tablet

Strength: 1000mg + 0.25mcg + 7.5mg

Form: Tablets

Reference Brands:

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.